Skip to main content

Emergency Management of Acute Intracerebral Hemorrhage

  • Chapter
  • First Online:
Neurointensive Care Unit

Part of the book series: Current Clinical Neurology ((CCNEU))

  • 1335 Accesses

Abstract

Intracerebral hemorrhage (ICH) accounts for up to 20% of acute cerebrovascular events and is the stroke type with the worst prognosis. Hematoma expansion is common after ICH and represents an appealing target for acute treatment; however, ICH still lacks a clinically proven anti-expansion therapy. The majority of ICH patients have high blood pressure in the acute phase. Intensive blood pressure reduction to systolic 140 mm Hg (but not below) appears safe and may improve outcome. Premorbid anticoagulant use increases the odds of hematoma expansion and death, and emergent coagulopathy reversal is typically used. The role of surgery in acute ICH remains controversial, and there is strong evidence in favor of decompressive surgery and hematoma evacuation only for cerebellar ICH with clinical deterioration and/or radiological evidence of brainstem compression. Infections, seizures, and deep venous thromboses are the main medical complications of ICH. Admission to a neurointensive care unit is associated with more favorable functional outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373(9675):1632–44.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.

    Article  PubMed  Google Scholar 

  3. Ikram MA, Wieberdink RG, Koudstaal PJ. International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep. 2012;14(4):300–6.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167–76.

    Article  PubMed  Google Scholar 

  5. Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68(2):116–21.

    Article  CAS  PubMed  Google Scholar 

  6. Toyoda K, Yasaka M, Nagata K, Nagao T, Gotoh J, Sakamoto T, et al. Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The Bleeding with Antithrombotic Therapy (BAT) retrospective study. Cerebrovasc Dis. 2009;27(2):151–9.

    Article  CAS  PubMed  Google Scholar 

  7. Pezzini A, Grassi M, Paciaroni M, Zini A, Silvestrelli G, Del ZE, et al. Antithrombotic medications and the etiology of intracerebral hemorrhage MUCH-Italy. Neurology. 2014;82(6):529–35.

    Article  CAS  PubMed  Google Scholar 

  8. Biffi A, Anderson CD, Jagiella JM, Schmidt H, Kissela B, Hansen BM, et al. APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol. 2011;10(8):702–9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Morotti A, Goldstein JN. Diagnosis and management of acute intracerebral hemorrhage. Emerg Med Clin North Am. 2016;34(4):883–99.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Leira R, Dávalos A, Silva Y, Gil-Peralta A, Tejada J, Garcia M, et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology. 2004;63(3):461–7.

    Article  CAS  PubMed  Google Scholar 

  11. Lord AS, Gilmore E, Choi HA, Mayer SA. Time course and predictors of neurological deterioration after intracerebral hemorrhage. Stroke. 2015;46(3):647–52.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Morotti A, Jessel MJ, Brouwers HB, Falcone GJ, Schwab K, Ayres AM, et al. CT angiography spot sign, hematoma expansion, and outcome in primary pontine intracerebral hemorrhage. Neurocrit Care. 2016;25(1):79–85.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Brouwers HB, Greenberg SM. Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis. 2013;35(3):195–201.

    Article  PubMed  Google Scholar 

  14. Flibotte JJ, Hagan N, O’Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63(6):1059–64.

    Article  CAS  PubMed  Google Scholar 

  15. Fassbender K, Grotta JC, Walter S, Grunwald IQ, Ragoschke-Schumm A, Saver JL. Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges. Lancet Neurol. 2017;16(3):227–37.

    Article  PubMed  Google Scholar 

  16. Gomes JA, Ahrens CL, Hussain MS, Winners S, Rasmussen PA, Uchino K. Prehospital reversal of warfarin-related coagulopathy in intracerebral hemorrhage in a mobile stroke treatment unit result of initial pilot implementation. Stroke. 2015;46(5):e118–20.

    Article  PubMed  Google Scholar 

  17. Claude Hemphill J, Lam A. Emergency neurological life support: intracerebral hemorrhage. Neurocrit Care. 2017;27:89–101.

    Article  PubMed  Google Scholar 

  18. Hemphill JC, Greenberg SM, Anderson C. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–60.

    Article  PubMed  Google Scholar 

  19. Morotti A, Goldstein JN. New oral anticoagulants and their reversal agents. Curr Treat Options Neurol. 2016;18(11):47.

    Article  PubMed  Google Scholar 

  20. Siegal DM, Crowther MA, Gross P, Weitz J, Weitz J, Ageno W, et al. Acute management of bleeding in patients on novel oral anticoagulants. Eur Heart J. 2013;34(7):489–98b.

    Article  CAS  PubMed  Google Scholar 

  21. Siegal DM. Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents. J Thromb Thrombolysis. 2015;39(3):395–402.

    Article  CAS  PubMed  Google Scholar 

  22. Cuker A, Siegal DM, Crowther MA, Garcia DA. Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants. J Am Coll Cardiol. 2014;64(11):1128–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Cordonnier C, Klijn CJM, Van Beijnum J, Al-Shahi Salman R. Radiological investigation of spontaneous intracerebral hemorrhage: systematic review and trinational survey. Stroke. 2010;41(4):685–90.

    Article  PubMed  Google Scholar 

  24. Webb AJS, Ullman NL, Morgan TC, Muschelli J, Kornbluth J, Awad IA, et al. Accuracy of the ABC/2 score for intracerebral hemorrhage. Stroke. 2015;46(9):2470–6.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Boulouis G, Morotti A, Charidimou A, Dowlatshahi D, Goldstein JN. Noncontrast computed tomography markers of intracerebral hemorrhage expansion. Stroke. 2017;48(4):1120–5.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Khosravani H, Mayer SA, Demchuk A, Jahromi BS, Gladstone DJ, Flaherty M, et al. Emergency noninvasive angiography for acute intracerebral hemorrhage. Am J Neuroradiol. 2013;34(8):1481–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Delgado Almandoz JE, Schaefer PW, Goldstein JN, Rosand J, Lev MH, González RG, et al. Practical scoring system for the identification of patients with intracerebral hemorrhage at highest risk of harboring an underlying vascular etiology: the secondary intracerebral hemorrhage score. Am J Neuroradiol. 2010;31(9):1653–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Hilkens NA, van Asch CJJ, Werring DJ, Wilson D, Rinkel GJE, Algra A, et al. Predicting the presence of macrovascular causes in non-traumatic intracerebral haemorrhage: the DIAGRAM prediction score. J Neurol Neurosurg Psychiatry. 2018 Jan 18. pii: jnnp-2017-317262. https://doi.org/10.1136/jnnp-2017-317262. [Epub ahead of print].

    Article  Google Scholar 

  29. Macellari F, Paciaroni M, Agnelli G, Caso V. Neuroimaging in intracerebral hemorrhage. Stroke. 2014;45(3):903–8.

    Article  PubMed  Google Scholar 

  30. Goldstein JN, Fazen LE, Snider R, Schwab K, Greenberg SM, Smith EE, et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology. 2007;68(12):889–94.

    Article  CAS  PubMed  Google Scholar 

  31. Oleinik A, Romero JM, Schwab K, Lev MH, Jhawar N, Delgado Almandoz JE, et al. CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke. 2009;40(7):2393–7.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Willinsky RA, Taylor SM, terBrugge K, Farb RI, Tomlinson G, Montanera W. Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology. 2003;227(2):522–8.

    Article  PubMed  Google Scholar 

  34. Qureshi AI. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage. Arch Neurol. 2010;67(5):570.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7(5):391–9.

    Article  PubMed  Google Scholar 

  36. Anderson C, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–65.

    Article  CAS  PubMed  Google Scholar 

  37. Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375(11):1033–43.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Morotti A, Brouwers HB, Romero JM, Jessel MJ, Vashkevich A, Schwab K, et al. Intensive blood pressure reduction and spot sign in intracerebral hemorrhage: a secondary analysis of a randomized clinical trial. JAMA Neurol. 2017;74(8):950–60.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Morotti A, Boulouis G, Romero JM, Brouwers HB, Jessel MJ, Vashkevich A, et al. Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion. Neurology. 2017;89(6):548–54.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Rodriguez-Luna D, Piñeiro S, Rubiera M, Ribo M, Coscojuela P, Pagola J, et al. Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. Eur J Neurol. 2013;20(9):1277–83.

    Article  CAS  PubMed  Google Scholar 

  41. Manning L, Hirakawa Y, Arima H, Wang X, Chalmers J, Wang J, et al. Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial. Lancet Neurol. 2014;13(4):364–73.

    Article  PubMed  Google Scholar 

  42. Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, et al. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2017 Nov 7. pii: S0735–1097(17)41517–8. https://doi.org/10.1016/j.jacc.2017.11.004. [Epub ahead of print].

    Article  PubMed  Google Scholar 

  43. Khan NI, Siddiqui FM, Goldstein JN, Cox M, Xian Y, Matsouaka RA, et al. Association between previous use of antiplatelet therapy and intracerebral hemorrhage outcomes. Stroke. 2017;48(7):1810–7.

    Article  PubMed  Google Scholar 

  44. Thompson BB, Bejot Y, Caso V, Castillo J, Christensen H, Flaherty ML, et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology. 2010;75(15):1333–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Baharoglu MI, Cordonnier C, Salman RA-S, de Gans K, Koopman MM, Brand A, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;6736(16):1–9.

    Google Scholar 

  46. Frontera JA, Lewin JJ, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook AM, et al. Guideline for reversal of Antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care. 2016;24(1):6–46.

    Article  CAS  PubMed  Google Scholar 

  47. Steiner T, Poli S, Griebe M, Hüsing J, Hajda J, Freiberger A, et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol. 2016;15(6):566–73.

    Article  CAS  PubMed  Google Scholar 

  48. Steiner T, Al-Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9:840–55.

    Article  PubMed  Google Scholar 

  49. Brophy GM, Human T, Shutter L. Emergency neurological life support: pharmacotherapy. Neurocrit Care. 2015;23(Suppl 2):S48–68.

    Article  PubMed  CAS  Google Scholar 

  50. Pollack CV, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373(6):511–20.

    Article  CAS  PubMed  Google Scholar 

  51. Eikelboom JW, Quinlan DJ, van Ryn J, Weitz JI, Ruff C, Giugliano R, et al. Idarucizumab: the antidote for reversal of dabigatran. Circulation. 2015;132(25):2412–22.

    Article  PubMed  Google Scholar 

  52. Mcgrath ER, Eikelboom JW, Kapral MK, O’Donnell MJ. Novel oral anticoagulants: a focused review for stroke physicians. Int J Stroke. 2014;9(1):71–8.

    Article  PubMed  Google Scholar 

  53. Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European heart rhythm association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2013;15(5):625–51.

    Article  PubMed  Google Scholar 

  54. Goldstein JN, Gilson a J. Critical care management of acute intracerebral hemorrhage. Curr Treat Options Neurol. 2011;13(2):204–16.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Chan S, Hemphill JC. Critical care management of intracerebral hemorrhage. Crit Care Clin. 2014;30(4):699–717.

    Article  PubMed  Google Scholar 

  56. Anderson CS, Arima H, Lavados P, Billot L, Hackett ML, Olavarría VV, et al. Cluster-randomized, crossover trial of head positioning in acute stroke. N Engl J Med. 2017;376(25):2437–47.

    Article  PubMed  Google Scholar 

  57. Hanley DF. Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage. Stroke. 2009;40(4):1533–8.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Hanley DF, Lane K, McBee N, Ziai W, Tuhrim S, Lees KR, et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017;389(10069):603–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. A Lancet. 2005;365:387–97.

    Article  PubMed  Google Scholar 

  60. Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382(9890):397–408.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Fung C, Murek M, Z’Graggen WJ, Krähenbühl AK, Gautschi OP, Schucht P, et al. Decompressive hemicraniectomy in patients with supratentorial intracerebral hemorrhage. Stroke. 2012;43(12):3207–11.

    Article  PubMed  Google Scholar 

  62. Hayes SB, Benveniste RJ, Morcos JJ, Aziz-Sultan MA, Elhammady MS. Retrospective comparison of craniotomy and decompressive craniectomy for surgical evacuation of nontraumatic, supratentorial intracerebral hemorrhage. Neurosurg Focus. 2013;34(5):E3.

    Article  PubMed  Google Scholar 

  63. Flaherty ML, Beck J. Surgery for intracerebral hemorrhage: moving forward or making circles? Stroke. 2013;44(10):2953–4.

    Article  PubMed  Google Scholar 

  64. Ramanan M, Shankar A. Minimally invasive surgery for primary supratentorial intracerebral haemorrhage. J Clin Neurosci. 2013;20(12):1650–8.

    Article  PubMed  Google Scholar 

  65. Beynon C, Schiebel P, Bösel J, Unterberg AW, Orakcioglu B. Minimally invasive endoscopic surgery for treatment of spontaneous intracerebral haematomas. Neurosurg Rev. 2015;38(3):421–8.

    Article  PubMed  Google Scholar 

  66. Zheng J, Li H, Guo R, Lin S, Hu X, Dong W, et al. Minimally invasive surgery treatment for the patients with spontaneous supratentorial intracerebral hemorrhage (MISTICH): protocol of a multi-center randomized controlled trial. BMC Neurol. 2014;14(1):1–6.

    Article  Google Scholar 

  67. Balami JS, Buchan AM. Complications of intracerebral haemorrhage. Lancet Neurol. 2012;11(1):101–18.

    Article  PubMed  Google Scholar 

  68. Morotti A, Marini S, Jessel MJ, Schwab K, Kourkoulis C, Ayres AM, et al. Lymphopenia, infectious complications, and outcome in spontaneous intracerebral hemorrhage. Neurocrit Care. 2017;26(2):160–6.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Schwarz S, Häfner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000;54(2):354–61.

    Article  CAS  PubMed  Google Scholar 

  70. Rincon F, Friedman DP, Bell R, Mayer SA, Bray PF. Targeted temperature management after intracerebral hemorrhage (TTM-ICH): methodology of a prospective randomized clinical trial. Int J Stroke. 2014;9(5):646–51.

    Article  PubMed  Google Scholar 

  71. Lord AS, Karinja S, Lantigua H, Carpenter A, Schmidt JM, Claassen J, et al. Therapeutic temperature modulation for fever after intracerebral hemorrhage. Neurocrit Care. 2014;21(2):200–6.

    Article  PubMed  Google Scholar 

  72. Westendorp WF, Vermeij JD, Zock E, Hooijenga IJ, Kruyt ND, Bosboom HJLW, et al. The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. Lancet. 2015;385(9977):1519–26.

    Article  CAS  PubMed  Google Scholar 

  73. Middleton S, McElduff P, Ward J, Grimshaw JM, Dale S, D’Este C, et al. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. Lancet. 2011;378(9804):1699–706.

    Article  PubMed  Google Scholar 

  74. Claude Hemphill Iii J. Improving outcome after intracerebral hemorrhage: maybe it is the body, not the brain. Neurocrit Care. 2017;26(2):157–9.

    Article  CAS  PubMed  Google Scholar 

  75. Lord AS, Langefeld CD, Sekar P, Moomaw CJ, Badjatia N, Vashkevich A, et al. Infection after intracerebral hemorrhage: risk factors and association with outcomes in the ethnic/racial variations of intracerebral hemorrhage study. Stroke. 2014;45(12):3535–42.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Morotti A, Marini S, Lena UK, Crawford K, Schwab K, Kourkoulis C, et al. Significance of admission hypoalbuminemia in acute intracerebral hemorrhage. J Neurol. 2017;264(5):905–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Pezzini A, Grassi M, Del Zotto E, Giossi A, Volonghi I, Costa P, et al. Complications of acute stroke and the occurrence of early seizures. Cerebrovasc Dis. 2013;35(5):444–50.

    Article  CAS  PubMed  Google Scholar 

  78. Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43(10):1175–80.

    Article  PubMed  Google Scholar 

  79. De Herdt V, Dumont F, Hénon H, Derambure P, Vonck K, Leys D, et al. Early seizures in intracerebral hemorrhage: incidence, associated. Neurology. 2011;77(20):1794–800.

    Article  PubMed  Google Scholar 

  80. Fogelholm R, Murros K, Rissanen A, Avikainen S. Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J Neurol Neurosurg Psychiatry. 2005;76(3):349–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, et al. Association of serum glucose concentrations during acute hospitalization with hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhage. Neurocrit Care. 2011;15(3):428–35.

    Article  CAS  PubMed  Google Scholar 

  82. Goldstein JN, Fazen LE, Wendell L, Chang Y, Rost NS, Snider R, et al. Risk of thromboembolism following acute intracerebral hemorrhage. Neurocrit Care. 2009;10(1):28–34.

    Article  CAS  PubMed  Google Scholar 

  83. Langhorne P, Fearon P, Ronning OM, Kaste M, Palomaki H, Vemmos K, et al. Stroke unit care benefits patients with intracerebral hemorrhage: systematic review and meta-analysis. Stroke. 2013;44(11):3044–9.

    Article  PubMed  Google Scholar 

  84. Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32(4):891–7.

    Article  PubMed  Google Scholar 

  85. Hwang DY, Dell CA, Sparks MJ, Watson TD, Langefeld CD, Comeau ME, et al. Clinician judgment vs formal scales for predicting intracerebral hemorrhage outcomes. Neurology. 2016;86(2):126–33.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Zahuranec DB, Brown DL, Lisabeth LD, Gonzales NR, Longwell PJ, Smith MA, et al. Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology. 2007;68(20):1651–7.

    Article  CAS  PubMed  Google Scholar 

  87. Holloway RG, Arnold RM, Creutzfeldt CJ, Lewis EF, Lutz BJ, McCann RM, et al. Palliative and end-of-life care in Stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(6):1887–916.

    Article  PubMed  Google Scholar 

  88. Ahmed N, Steiner T, Caso V, Wahlgren N. Recommendations from the ESO-Karolinska stroke update conference, Stockholm 13–15 November 2016.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joshua N. Goldstein .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Morotti, A., Goldstein, J.N. (2020). Emergency Management of Acute Intracerebral Hemorrhage. In: Nelson, S., Nyquist, P. (eds) Neurointensive Care Unit. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-030-36548-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-36548-6_10

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-36547-9

  • Online ISBN: 978-3-030-36548-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics